GAMT-D (EC 2.1.1.2) was first described in 1994 in a 22-month-old boy with cerebral creatine deficiency, developmental delay, and progressive extrapyramidal symptoms [3,10]. This evidence concerns the gene GAMT and Global developmental delay.